To identify factors that account for variation in complication rates across hospitals and surgeons performing lumbar spinal fusion surgery.
Discharge registry including all non-federal hospitals in Washington State from 2004–2007.
We identified adults (n = 6,091) undergoing an initial inpatient lumbar fusion for degenerative conditions. We identified whether or not each patient had a subsequent complication within 90 days. Logistic regression models with hospital and surgeon random-effects were used to examine complications, controlling for patient characteristics and comorbidity.
Complications within 90 days of a fusion occurred in 4.8% of patients, and 2.2% had a reoperation. Hospital effects accounted for 8.8% of the total variability, and surgeon effects account for 14.4%. Surgeon-factors account for 54.5% of the variation in hospital reoperation rates, and 47.2% of the variation in hospital complication rates. The discretionary use of operative features, such as the inclusion of Bone Morphogenetic Proteins, accounted for 30% and 50% of the variation in surgeons’ reoperation and complication rates, respectively.
To improve the safety of lumbar spinal fusion surgery, quality improvement efforts that focus on surgeons’ discretionary use of operative techniques, may be more effective than those that target hospitals.
Low back pain is a condition for which expanding treatments and surgical innovation have outpaced supporting scientific evidence of their effectiveness.{
Post-operative complications may be influenced by the choice of surgical technique, {
Using a statewide inpatient discharge registry that allowed us to link successive episodes of care for the same patient across multiple years and institutions, we sought to determine the rates of postoperative complications following fusion for degenerative disease, assess the variation in these rates across individual hospitals and surgeons, and identify how much of the variation is accounted for by operative features.
The Comprehensive Hospital Abstract Reporting System (CHARS) is an inpatient discharge database of all non-federal hospitals in Washington State.{
We identified adults (age 20 or older) who underwent an initial inpatient thoracolumbar, lumbar, or lumbosacral fusion operation for degenerative spinal conditions from 2004 through 2007. This starting year (2004) was selected because it corresponds to the first calendar year that codes for three or more disc levels fused (4 or more vertebrae) became available. Patients were identified using relevant diagnosis and procedure codes from the October, 2010 update of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM).{
CHARS allows up to nine diagnosis codes and up to six procedure codes for each admission. We searched all codes to identify patients undergoing fusion surgery for common degenerative spinal conditions, including disc degeneration (e.g. spondylosis), herniated discs, stenosis, spondylolisthesis, and scoliosis. We did not include patients who had non-degenerative spinal admissions in the previous year, such as spinal fracture, vertebral dislocation, spinal cord injury, or inflammatory spondylopathy. We also excluded patients who, in the previous year, had inpatient admission codes for accidents, neoplasm, HIV or immune deficiency, intraspinal abcess, osteomyelitis, infection, pregnancy, and cervical or thoracic spinal diagnoses and/or procedures.
All lumbar fusions were included, whether or not they were combined with a discectomy or laminectomy. Patients who had other types of spine-related procedures, including artificial disc replacement, corpectomy, osteotomy, kyphectomy, insertion of spacers, and insertion of dynamic stabilizing devices were excluded even if these were performed in conjunction with a fusion operation. We also excluded patients who, in the preceding 10 years, had any type of prior lumbar spine surgery, or had diagnosis or procedure codes that implied a previous lumbar operation (such as “reopening of laminectomy site”, “refusion”, or “removal of an internal fixation device”). Previous surgery has been shown to be an important predictor of higher complication and repeat surgery rates {
We created a composite indicator of 90 day major surgical complications, defined as postoperative device complication, life-threatening complication, wound problem, or death occurring within 90 days. We separately examined the rates of repeat lumbar spine surgery. The presence of each complication (or repeat surgery) was coded as a dichotomous variable based on ICD-9-CM diagnosis and procedure codes. Each complication was attributed to the hospital and attending surgeon performing the initial fusion, and was not counted as an index case or a complication for another hospital or surgeon.
Repeat surgery was identified as the first instance of any second lumbar spine operation (i.e. “reoperation”) and not necessarily a repeat of the same procedure or performed at the same vertebral level. Device complications were based ICD-9-CM diagnosis and procedure codes that indicate a problem with an internal orthopaedic device (e.g. “malfunction of orthopaedic device”). We did not count device complications or repeat spinal surgeries coded during the index admission, and also required that they be co-coded with a lumbar spine-specific diagnosis and/or procedure code.
We counted wound problems, life-threatening complications, and death if they occurred during the 90-day postoperative surveillance or during the index admission. We followed
Patient characteristics and operative features may explain variation in rates of complications and repeat surgery across hospitals and surgeons. We adjusted the rates of complications for differences due to patient age, sex, comorbidity, diagnosis, and primary insurance. We used Quan’s “enhanced” version of the Charlson index (categorized “none”, “one”, and “two or more”) to adjust for comorbidity, applying it to admissions occurring at or during the year preceding each index visit.{
The primary source of payment was coded into the following groups: “Medicare”, “Medicaid”, “Health maintenance organization” (e.g. Kaiser, Group Health Cooperative), “Commercial insurance” (e.g. Mutual of Omaha, United Health Plan, Safeco), “Workers’ compensation”, “Health service contractor” (e.g. Premera, Premera/Blue Cross), and “Other”. The latter category included charity cases, self-pay, and “other government sponsored patients” (e.g. Tri-care, CHAMPUS, Indian Health, Corrections) that combine to account for 2.5% of the total cases. Variables for race or ethnicity were not provided in CHARS during the study years.
Some operative features that may be associated with outcomes are identifiable from ICD-9 codes, including use of bone morphogenetic protein (BMP), surgical approach (anterior, posterior, or combined/circumferential), an indicator of whether fusion was combined with a decompression, and an indicator of whether 3+ disc levels were fused.{
Bivariate associations between patient characteristics and complications were assessed using chi-square or t-test comparisons. We examined the risk for complications using logistic regression analysis, including only patients who had a minimum of 90 days of surveillance available in order to assess each outcome. For example, patients who had an initial operation in December of 2007 were not eligible to be assessed for the 90 day outcomes because the data only extend through 2007.
We used a logistic regression model that allowed a random-intercept for each hospital.{
To compare risk-adjusted outcomes across hospitals, we used the results from the logistic regression models to estimate the risk of complication for an “average” patient. This was accomplished by setting the covariates for age, sex, comorbidity, insurance, and diagnosis to the mean statewide distributions and then reporting the mean rate of complications within each hospital, along with a 95% Empirical Bayes confidence interval.
To examine the influence of surgeon factors on the rates of complications, we then added an additional random-effect parameter to the previous (“hospital only”) model. This parameter represents the variability attributed to surgeons’ “nested” within each of the hospitals he/she operated in.
Model construction was based on the principles by Hosmer & Lemeshow (2000), including checking for interactions. We used likelihood ratio and Aikake’s Information Criteria (AIC) to identify the models with the best fit. An advantage of AIC is that it allows comparisons of models with the same number of parameters; a useful consideration when comparing random-effects models. The best-fitted model, with the lowest AIC, included patient and operative features along with surgeon random-effect. The specification for this final model, along with 95% Bayesian coverage intervals is:
In this specification,
We found no evidence of a poorly fitted model for complication (p = 0.5615) using Hosmer-Lemeshow goodness-of-fit statistic. We confirmed linearity between the logarithmic odds for reoperations with each of the variables in the model; and no issues were identified that forced us to transform any variables. No changes in parameter coefficients as variables were added to the model suggested evidence of multicolinearity; this was confirmed by examining variance inflation factors and tolerance statistics in the final model.
In all models we assumed that the random effects were additive and normally distributed. Empirical Bayes predictions of the random-effects were assessed for normality using a Q-Q plot. There were no serious violations in the random-effect distribution through the bulk of the data. However, at the high-end of the random-effect spectrum, several surgeons’ complication rates deviated higher than predicted; indicating that that they had unusually high complication rates. This finding translates into a conservative estimation (underestimate of their actual rates) of the complication rates for these particular surgeons, because they are “over-fitted” toward the overall state mean. Our final model had a C-statistic of 0.662 for the complication model and 0.660 for reoperation model.
We then estimated the proportion of total variation that was explained by the inclusion of hospital (or surgeon) effects. The total variability for a random-effect model of a dichotomous outcome is calculated as the sum of hospital (surgeon) -specific variance(s) (ψ) plus the mathematical constant π2/3 {
An Intraclass Correlation Coefficient (ICC) was calculated for hospital (surgeon) effects to estimate the proportion of variation explained
To measure the proportion of hospital (surgeon) variation that was explained by the addition of covariates, a model with only random-effects (null) was compared to subsequent models with covariates. A reduction in the ICC as covariates are added to the model represents the proportion of hospital (surgeon) variation that is explained at that level by the added covariates.
We also examined our findings after excluding 6 (24%) hospitals that included only one surgeon who performed fusions because, in these instances, the random-effect models cannot differentiate the variation in complications at the hospital level from that of the surgeon level. All analyses were performed using Stata-MP, version 11 (College Station, TX), with hypothesis testing performed using a two-sided alpha level set at 0.05.
A total of 7,680 patients were identified as having an initial inpatient fusion for lumbar degenerative conditions between 2004 and 2007. A total of 1,589 (20.7%) were excluded for reasons shown in
The study population consisted of 6,091 patients who had an initial inpatient spinal fusion during the study period (
Age between 61 and 80, greater comorbidity, and Medicare and Medicaid insurance were associated with higher risk of having a complication within 90 days (
Unadjusted complication rates for herniated disc without myelopathy (2.6%) were lower than for disc degeneration (4.2%), spondylolisthesis (4.5%), spinal stenosis (6.4%), herniated disc with myelopathy (8.6%), or scoliosis (9.7%). Complications were not mutually exclusive. For example, the same patient may have had a device complication and a reoperation. Wound problems were the most common type of complications (3.1%), followed by repeat surgery (2.2%), life- threatening complications (2.0%), device problems (0.8%), and death (0.2%). Those with a diagnosis of scoliosis had a higher rate of complications than all other diagnoses, including a mortality rate of 1.2%.
Anterior operative approaches were associated with a significantly higher risk for 90 day repeat surgery (OR 3.33; 95% CI 2.03 – 5.44), even after adjusting for patient characteristics, comorbidity, diagnosis, insurance status, and other operative features. Circumferential fusions were associated with a higher 90 day risk for complications (OR 1.24; 95% CI 0.82–1.89) and reoperations (OR 1.13; 95% CI 0.59–2.17); but did not reach statistical significance in this small subset of patients. Patients who had 3+ disc levels fused had a higher risk for complications (OR 1.64 95% CI 1.12 – 2.40).
Higher surgeon case volume was not associated with a significantly lower 90 day repeat surgery or complication rate. The use of bone morphogenetic proteins (BMP) was associated with a non-significantly higher risk for complication (OR 1.20; 95% CI 0.88 – 1.63) and repeat surgery (OR 1.78; 95% CI 1.17 – 2.69). Having 3+ disc levels fused was also associated with an increased risk for complication (OR 1.64 95% CI 1.12 – 2.40) and repeat surgery (OR 1.78 95% CI 1.17 – 2.69).
Scoliosis was associated with a higher risk for complications within a given surgeon, while the risk for stenosis, spondylolisthesis, and herniated disk did not significantly differ from that of disc degeneration. Stenosis was associated with higher reoperation rates within a given surgeon, compared to degenerative disc disease. Adjusting for operative features lowered the odds ratio for complications among those with scoliosis from 1.94 (95% CI 1.23 – 3.09, not shown) to 1.58 (1.25 – 3.87, final model.)
The rates for complications are shown in
Surgeon effects accounted for 14.4% of the total variation in reoperations and 5.0% of the total variation for complications. Surgeon-level variation for both repeat surgery and complications was greater than the variation observed among hospitals. For example, the variance for the surgeon effects for repeat surgery was 0.341 (9.0% of total), compared to 0.153 (4.0%) for hospitals.
The addition of patient characteristics did not reduce the variability in reoperation rates, but accounted for 32.6% of the between-surgeon variation in complication rates. The addition of operative features accounted for 4.4% of the total variation in reoperations (30% of the variability between surgeons), and 2.5% of the total variation in complications (50% of the between-surgeon variation).
The unadjusted rate of repeat lumbar spine surgery in our cohort was 2.2% at 90 days and 5.0% at 1 year. We found that 115/137 (84%) of the reoperations were performed by the same surgeon who performed the initial surgery. The most common diagnoses at the time of these reoperations was spinal stenosis (21.2%), followed by disc degeneration (18.3%), spondylolisthesis (17.5%), disc herniation with myelopathy (13.1%), disc herniation (6.6) and scoliosis (5.8%). The remaining 16.1% were for non-degenerative diagnoses such as removal of internal orthopaedic device or surgical aftercare. Device complication codes were included in 36/137 (26%) of the all repeat surgeries within 90 days, and the code for “arthrodesis status” (implying a problem at the same vertebral level as the index surgery) in 53/137 (38.7%). The most common procedures coded at the time of reoperation were fusion or re-fusion (51.8%), decompression only (22.6%), and other spinal procedures such as removal of orthopaedic devices (25.5%).
Complications within 90 days of an initial lumbar fusion operation for a degenerative diagnosis occurred in 4.9% of patients, and 2.2% of patients had a second operation within 90 days. After adjusting for patient characteristics and diagnosis we found that the mean 90-day complication rate for individual surgeons varied from 2.5% to 11.7%. The range for reoperations varied from 0.6% to 9.3%.
Estimating complications is notoriously difficult in studies involving surgical treatments; a fact that is reflective of the large unexplained variation in our models. Our findings that the majority of the total variability (~85%) occurred within (rather than between) surgeons or hospitals, suggests that complications and reoperations may be more encounter-specific than they are due to systematic difference in quality across surgeons or hospitals.
Nevertheless, the “explainable” variation among hospitals in the rate of complications was substantially reduced after including surgeon effects in our models. Furthermore, the discretionary use of BMP, 3+ disc levels fused, and surgical approach, accounts for 50% and 30% of the variation among surgeons’ complication and repeat surgery rates, respectively. This suggests that for improving safety, the addition of surgeon quality improvement efforts may be more effective than those solely targeting the hospital. However, surgeon quality improvement programs should not necessarily replace current hospital-level quality efforts.
Among 6,091 initial fusions, 366 patients had either a complication or a repeat surgery within 90 days (6.1%). When these were further examined within each type of adverse event, or attributed to individual providers, the uncertainty surrounding individual estimates became larger, potentially rendering individual surgeon estimates less informative. Taken in combination, these results highlight a conundrum facing policymakers: though discretionary physician decision-making may be a key to improving surgical safety, the low precision of surgeon-level empirical performance of complications in these data identified only a small number (3.7%) of surgeons with complication rates statistically above the statewide mean. Future efforts should examine provider-level empirical performance data in other populations and in relationship to external benchmarks that are not derived from the data. {Jones et al. 2010} At a policy level, the question is whether acting on surgeon-level adverse event data, with this known imprecision, will lead to better delivery of health care to a population. While the most serious or frequent harms that may arise from fusion operations may lead to more detailed review of a small number of specific surgeons, surgeon focused quality improvement efforts alone may be useful to address preventable harms.
The finding of a lower adverse event rate in the workers’ compensation population may seem surprising. Patient-reported outcomes of surgical procedures, including lumbar fusion, are consistently worse for workers’ compensation compared to non-workers’ compensation populations.{
In our data, we could not corroborate
Administrative data generally allow for a longer duration of follow-up than clinical studies, and can often identify subsequent care even when it occurs at a different institution. Despite these strengths, our study has a number of limitations that arise from the analysis of observational data. Such data are susceptible to confounding factors that limit causal inference. The presence of such an unmeasured factor would have to have a large effect and be systematically disproportionate across providers in order to alter individual estimates. By excluding significant comorbidity, non-degenerative spinal pathology and previous surgery, as well as adjusting our model for comorbidity and diagnoses, we have accounted for some of this potential confounding.
The complication rates that we report may be an underestimate of the actual rates because we only counted those that were associated with a readmission. Some postoperative events, such as pneumonia, might have been treated in an outpatient setting and not counted as an adverse event in our analysis. In addition, the use of normally distributed random-effects results in a conservative estimation for a few providers with higher than expected rates. Future efforts should use sampling techniques to fit non-normally distributed random effects.
Although ICD-9-CM codes are commonly used in spinal research, they lack specific clinical detail, such as disease severity or pain intensity, specification of exact vertebral levels, and functioning. While this may lead to some imprecision, administrative data are reliable for ascertaining major complications.{
We could not account for patient migration into or out of Washington State, which may influence the rates of complications that we observed. In addition, we were unable to identify lumbar operations occurring in our cohort prior to 1987, or those that occurred outside of Washington State. As a result, some patients in our analysis may have had a previous lumbar operation that was unknown to us.
The use of administratively derived patient safety indicators following fusion surgery has not been rigorously validated through a comparison of chart reviews. However, readmission, infections, mortality, and life-threatening complications are part of the National Surgical Quality Improvement Program (NSQIP) which has been used as the gold standard to improve the validity of patient safety indicators {
Safety data regarding spine surgery are available from only a few randomized trials. The Sport Patient Outcomes Research Trial (SPORT) did not focus on differences in outcomes based on the type of operative feature, was not limited to fusion procedures, and did not primarily focus on safety.{
Joint Acknowledgement/Disclosure Statement:
Dr. Martin receives partial salary support or consulting fees for work on several back pain-related research grants funded by the NIH, AHRQ and the National Bureau of Economic Research (NBER). Within the past five years Dr. Martin received partial salary support through a gift to the University of Washington from Surgical Dynamics (now acquired by Stryker Corporation), a maker of surgical implants.
Dr. Franklin is a principal investigator for CDC Grant #5R21CE001850-02, but does not receive any salary from this.
Dr. Lurie receives salary support from Dartmouth Hitchcock Medical Center and Dartmouth College with grant funding from NIH and AHRQ. He has also served as a paid consultant to Blue Cross Blue Shield Corporation, the Foundation for Informed Medical Decision Making, Baxano Inc., FzioMed Inc., and NewVert Ltd.
Dr. MacKenzie has no disclosures.
Dr. Deyo holds a professorship endowed by a gift to Oregon Health and Science University from Kaiser Permanente. He receives honoraria for serving on the Board of Directors for the non-profit Foundation for Informed Medical Decision Making. He also receives honoraria from Up To Date for authoring topics on low back pain. He receives honoraria from the Robert Wood Johnson Foundation for serving on a National Advisory Committee to a physician research training program. He is the principal investigator, co-investigator, or consultant for multiple grants from the NIH and AHRQ. No other disclosures.
Dr. Mirza is the PI of an AHRQ research grant to examine the safety of spinal surgery. He receives royalties for a patented surgical drill, through the University of Washington’s Technology Transfer Office. Within the past five years his research benefitted from support of a gift to the University of Wahington from Surgical Dynamics (now acquired by Stryker Corporation), a maker of surgical implants.
Risk-adjusted 90 day repeat surgery (top row) and complication (bottom row) rates following inpatient lumbar spinal fusion surgery for common degenerative diagnoses. Each spike represents 95% Bayesian confidence interval for the rates within a hospital (left) or surgeon nested within hospitals (right) in Washington State. The solid horizontal line represents the statewide mean.
Reasons for exclusion from lumbar fusion safety study. Washington State Comprehensive abstract reporting system, 2004–2007.
| Exclusion factors (not mutually exclusive) | Number excluded (n = 1589) |
|---|---|
| Cancer in previous year | 114 |
| Trauma in previous year | 88 |
| Drug abuse in previous year | 30 |
| Neurological impairment in previous year | 20 |
| HIV or immune deficiency in previous year | 2 |
| Intraspinal abscess in previous year | 12 |
| Osteomyelitis in previous year | 41 |
| Pregnancy in previous year | 8 |
| Non-degenerative spinal diagnosis in previous year (vertebral fracture, spinal cord injury, congenital anomaly, inflammatory spondylopathy, osteoporosis) | 103 |
| Lumbar spine surgery in previous 10 years | 1,313 |
| Any of the above | 1,589 |
Rates for any postoperative adverse events following lumbar spinal fusion surgery for common degenerative diagnoses (CHARS 2004–2007).
| Complications (or death) within 90 days, n(%) | Repeat lumbar surgery | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number (Column %) | Any | Device problem | Wound | Life threat | Death | 90-days | 1-year | ||
| Number eligible surveillance | 6091 | 6091 | 4805 | ||||||
| Number of complications or repeat surgery (%) | 298 (4.9) | 49 (0.8) | 191 (3.1) | 124 (2.0) | 14 (0.2) | 137 (2.2) | 238 (5.0) | ||
| Age group | 20–40 | 836 (13.7%) | 29 (3.5) | 7 (0.8) | 17 (2.0) | 11 (1.3) | 0 (0) | 13 (1.6) | 29 (4.2) |
| 41–60 | 2,781 (45.7%) | 120 (4.3) | 24 (0.9) | 78 (2.8) | 42 (1.5) | 4 (0.1) | 65 (2.3) | 103 (4.7) | |
| 61–80 | 2,273 (37.3%) | 138 (6.1) | 18 (0.8) | 90 (4.0) | 64 (2.8) | 9 (0.4) | 56 (2.5) | 100 (5.6) | |
| 81+ | 201 (3.3%) | 11 (5.5) | 0 (0) | 6 (3.0) | 7 (3.5) | 1 (0.5) | 3 (1.5) | 6 (3.7) | |
| Sex, % | Male | 2,391 (39.8%) | 92 (3.8) | 8 (0.3) | 52 (2.2) | 44 (1.8) | 8 (0.3) | 39 (1.6) | 89 (4.7) |
| Female | 3,700 (60.7%) | 206 (5.6) | 41 (1.1) | 139 (3.8) | 80 (2.2) | 6 (0.2) | 98 (2.6) | 149 (5.1) | |
| Charlson, % | None | 4,434 (72.8%) | 175 (3.9) | 36 (0.8) | 100 (2.3) | 66 (1.5) | 7 (0.2) | 94 (2.1) | 173 (5.0) |
| 1 | 1,268 (20.8%) | 86 (6.8) | 11 (0.9) | 63 (5.0) | 34 (2.7) | 5 (0.4) | 33 (2.6) | 46 (4.6) | |
| 2+ | 389 (6.4%) | 37 (9.5) | 2 (0.5) | 28 (7.2) | 24 (6.2) | 2 (0.5) | 10 (2.6) | 17 (5.8) | |
| Payer, % | Medicare | 1,909 (31.3%) | 127 (6.7) | 10 (0.5) | 85 (4.5) | 68 (3.6) | 8 (0.4) | 42 (2.2) | 71 (4.8) |
| Medicaid | 374 (6.1%) | 32 (8.6) | 6 (1.6) | 25 (6.7) | 8 (2.1) | 0 (0.0) | 10 (2.7) | 19 (6.4) | |
| HMO | 558 (9.2%) | 18 (3.2) | 7 (1.3) | 6 (1.1) | 4 (0.7) | 3 (0.5) | 10 (1.8) | 15 (3.2) | |
| Commercial | 1,154 (18.9%) | 45 (3.9) | 13 (1.1) | 21 (1.8) | 16 (1.4) | 2 (0.2) | 36 (3.1) | 55 (5.9) | |
| WC | 686 (11.3%) | 19 (2.8) | 7 (1.0) | 12 (1.7) | 4 (0.6) | 0 (0.0) | 11 (1.6) | 29 (5.3) | |
| Contract | 1,271 (20.9%) | 51 (4.0) | 6 (0.5) | 38 (3.0) | 21 (1.7) | 1 (0.1) | 25 (2.0) | 46 (4.7) | |
| Other | 139 (2.3%) | 6 (4.3) | 0 (0.0) | 4 (2.9) | 3 (2.2) | 0 (0.0) | 3 (2.2) | 3 (2.8) | |
| Length of stay, mean days (SD) | With AE | 298 (4.9%) | 5.0 (sd 3.6) | 4.7 (3.0) | 4.8 (3.5) | 5.1 (3.4) | 7.3 (6.6) | 4.3 (2.8) | 4.2 (2.6) |
| Without AE | 5,793 (95.1%) | 3.8 (sd 2.4) | 3.8 (2.4) | 3.8 (2.4) | 3.8 (2.4) | 3.8 (2.4) | 3.8 (2.4) | 3.9 (2.5) | |
| Overall | 6,091 (100%) | 3.9 (sd 2.5) | 3.9 (2.5) | 3.9 (2.5) | 3.9 (2.5) | 3.9 (2.5) | 3.9 (2.5) | 3.9 (2.5) | |
| Diagnosis | Disc Deg. | 1097 (18.0%) | 46 (4.2%) | 9 (0.8) | 26 (2.4) | 21 (1.9) | 0 (0) | 23 (2.1) | 46 (5.3) |
| Herniated | 575 (9.4%) | 15 (2.6%) | 4 (0.7) | 10 (1.7) | 4 (0.7) | 0 (0) | 8 (1.4) | 17 (3.7) | |
| Herniated disc with myelopathy | 140 (2.3%) | 12 (8.6%) | 1 (0.7) | 8 (5.7) | 5 (3.6) | 0 (0) | 3 (2.1) | 11(10.2) | |
| Stenosis | 549 (9.0%) | 35 (6.4%) | 3 (0.5) | 25 (4.6) | 14 (2.6) | 2 (0.4) | 20 (3.6) | 28 (6.4) | |
| Spondylolisthesis | 3,296 (54.1%) | 148 (4.5%) | 27 (0.8) | 93 (2.8) | 59 (1.8) | 7 (0.2) | 71 (2.2) | 117 (4.5) | |
| Scoliosis | 434 (7.1%) | 42 (9.7%) | 5 (1.2) | 29 (6.7) | 21 (4.8) | 5 (1.2) | 12 (2.8) | 19 (5.6) | |
| Procedure | Fusion only | 2,179 (35.8%) | 122 (5.6) | 23 (1.1) | 84 (3.9) | 56 (2.6) | 1 (0.0) | 49 (2.2) | 82 (4.7) |
| Fus + deco | 3,912 (64.2%) | 176 (4.5) | 26 (0.7) | 107 (2.7) | 68 (1.7) | 13 (0.3) | 88 (2.2) | 156 (5.1) | |
| Instrumentation | No | 2203 (36.2%) | 119 (5.4%) | 18 (0.8%) | 79 (3.6%) | 51 (2.3) | 9 (0.4) | 44 (2.0) | 85 (4.7) |
| Yes | 3888 (63.8%) | 179 (4.6%) | 31 (0.8%) | 112 (2.9%) | 73 (1.9) | 5 (0.1) | 93 (2.4) | 153 (5.1) | |
| Multilevel | No | 5,612 (92.1%) | 250 (4.5) | 43 (0.8) | 159 (2.8) | 98 (1.7) | 11 (0.2) | 123 (2.2) | 212 (4.8) |
| Yes | 479 (7.9%) | 48 (10.0) | 6 (1.3) | 32 (6.7) | 26 (5.4) | 3 (0.6) | 14 (2.9) | 26 (7.0) | |
| BMP | No | 4,924 (80.8%) | 237 (4.8) | 31 (0.6) | 164 (3.3) | 99 (2.0) | 11 (0.2) | 89 (1.8) | 174 (4.4) |
| Yes | 1,167 (19.2%) | 61 (5.2) | 18 (1.5) | 27 (2.3) | 25 (2.1) | 3 (0.3) | 48 (4.1) | 64 (7.4) | |
| Approach | Posterior | 4926 (80.9%) | 237 (4.8) | 37 (0.8) | 158 (3.2) | 99 (2.0) | 12 (0.2) | 87 (1.8) | 157 (4.1) |
| Anterior | 690 (11.3%) | 31 (4.5) | 7 (1.0) | 13 (1.9) | 10 (1.4) | 1 (0.1) | 37 (5.4) | 57 (10.6) | |
| Circum. | 475 (7.8%) | 30 (6.3) | 5 (1.1) | 20 (4.2) | 15 (3.2) | 1 (0.2) | 13 (2.7) | 24 (5.7) | |
| Surgeon fusion volume quartile | 1 – 33 | 1,539 (25.3) | 67 (4.4) | 9 (0.6) | 44 (2.9) | 29 (1.9) | 4 (0.3) | 29 (1.9) | 66 (5.3) |
| 34 – 64 | 1,535 (25.2) | 82 (5.3) | 15 (1.0) | 48 (3.1) | 33 (2.1) | 3 (0.2) | 42 (2.7) | 75 (6.2) | |
| 65 – 96 | 1,512 (24.8) | 85 (5.6) | 12 (0.8) | 58 (3.8) | 36 (2.4) | 4 (0.3) | 41 (2.7) | 53 (4.3) | |
| 97 – 227 | 1,505 (24.7) | 64 (4.3) | 13 (0.9) | 41 (2.7) | 26 (1.7) | 3 (0.2) | 25 (1.7) | 44 (4.0) | |
significant difference within categories of variable (<0.05)
Surgeon 1-year fusion volume group is based on fusion volume for any type of fusion or re-fusion prior to applying exclusion criteria.
Multivariate analysis of repeat surgery and complications and within 90 days of an initial inpatient lumbar fusion in Washington State (CHARS 2004–2007)
| Final models using surgeon-level random effects. | |||
|---|---|---|---|
| Characteristics | Reoperation within 90 days | Other major complication | |
| Age group | 20–40 | 1.00 (ref) | 1.00 (ref) |
| 41–60 | 1.41 (0.76 – 1.78) | 1.15 (0.85 – 2.06) | |
| 61–80 | 1.73 (0.73 – 1.96) | 1.17 (0.78 – 2.14) | |
| 80+ | 1.04 (0.44 – 2.14) | 0.90 (0.45 – 2.38) | |
| Sex | Male | 1.00 (ref) | 1.00 (ref) |
| Female | 1.63 (1.01 – 1.71) | 1.31 (0.97 – 1.66) | |
| Any comorbidity | None | 1.00 (ref) | 1.00 (ref) |
| One | 1.16 (1.20 – 2.07) | 1.57 (1.19 – 2.09) | |
| Two or more | 1.24 (1.41 – 3.05) | 2.05 (1.49 – 3.28) | |
| Insurance | Medicare | 1.00 (ref) | 1.00 (ref) |
| Medicaid | 1.49 (0.66 – 3.39) | 1.50 (0.89 – 2.40) | |
| HMO | 1.11 (0.51 – 2.44) | 0.63 (0.30 – 0.98) | |
| Commercial | 1.31 (0.73 – 2.35) | 0.69 (0.42 – 1.03) | |
| W/C | 0.99 (0.45 – 2.22) | 0.62 (0.33 – 1.05) | |
| Contract | 0.95 (0.52 – 1.76) | 0.71 (0.45 – 1.01) | |
| Other | 1.14 (0.33 – 3.98) | 0.77 (0.31 – 1.80) | |
| Diagnosis | Disc Deg | 1.00 (ref) | 1.00 (ref) |
| HNP | 0.90 (0.39 – 1.32) | 0.72 (0.69 – 1.60) | |
| HNP w/myelop | 0.94 (0.27 – 3.31) | 2.08 (1.05 – 4.12) | |
| Stenosis | 2.44 (1.26 – 4.75) | 1.37 (0.71 – 1.48) | |
| Listhesis | 1.45 (0.85 – 2.49) | 0.99 (0.70 – 1.33) | |
| Scoliosis | 1.75 (0.77 – 3.95) | 1.58 (1.24 – 3.87) | |
| Surgeon previous year volume quartile | 1 – 29 | 1.00 (ref) | 1.00 (ref) |
| 30 – 60 | 1.41 (0.84 – 2.36) | 1.21 (0.85 – 1.70) | |
| 61 – 93 | 1.22 (0.70 – 2.11) | 1.21 (0.84 – 1.73) | |
| 94 – 242 | 0.94 (0.50 – 1.78) | 1.03 (0.69 – 1.52) | |
| Surgical Approach | Posterior | 1.00 (ref) | 1.00 (ref) |
| Anterior | 3.33 (2.03 – 5.44) | 0.98 (0.64 – 1.50) | |
| Combined | 1.13 (0.59 – 2.17) | 1.24 (0.82 – 1.89) | |
| BMP | No | 1.00 (ref) | 1.00 (ref) |
| Yes | 1.78 (1.17 – 2.69) | 1.20 (0.88 – 1.63) | |
| four or more vertebrae fused | No | 1.00 (ref) | 1.00 (ref) |
| Yes | 1.22 (0.64 – 2.32) | 1.64 (1.12 – 2.40) | |
Odds ratio based on generalized linear & latent mixed models using Stata-MP command (GLLAMM)
Random-effects variance and model fit parameters of multivariate models for repeat surgery and complications within 90 days of an initial inpatient lumbar fusion in Washington State (CHARS 2004–2007)
| Fixed effects | Random-effects | Hospital level variance (% of total variability) | Surgeon level variance (% of total variability) | Reduction in total variability compared to null model | Reduction in hospital and surgeon variability compared to null model | df | AIC | LL |
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| Hospital | 0.318 (8.8%) | -- | -- | -- | 2 | 1294.4 | −644.91 | |
| Surgeon | -- | 0.551 (14.4 %) | -- | -- | 2 | 1287.2 | −641.61 | |
| Both | 0.153 (4.0%) | 0.341 (9.0%) | -- | -- | 3 | 1290.5 | −642.26 | |
| Hospital | 0.331 (9.1%) | -- | 0% | 0% | 19 | 1306.5 | −634.20 | |
| Surgeon | -- | 0.567 (14.7%) | 0% | 0% | 19 | 1298.8 | −630.40 | |
| Both | 0.150 (3.9%) | 0.361 (9.5%) | 0% | 0% | 20 | 1302.8 | −631.41 | |
| Hospital | 0.269 (7.6%) | -- | 1.3% | 15.1% | 26 | 1278.8 | −613.40 | |
| Surgeon | -- | 0.383 (10.4%) | 4.4% | 30.4% | 26 | 1276.3 | −612.41 | |
| Both | 0.133 (3.6%) | 0.250 (6.8%) | 3.0% | 22.6% | 27 | 1278.3 | −612.16 | |
| Hospital | 0.124 (3.6%) | -- | -- | 2 | 2376.2 | −1186.11 | ||
| Surgeon | -- | 0.174 (5.0%) | -- | -- | 2 | 2372.3 | −1184.14 | |
| Both | 0.065 (1.9%) | 0.112 (2.6%) | -- | -- | 3 | 2375.8 | −1184.89 | |
| Hospital | 0.07 (2.1%) | -- | 1.7% | 43.4% | 19 | 2327.7 | −1144.85 | |
| Surgeon | -- | 0.118 (3.4%) | 1.7% | 32.6% | 19 | 2326.2 | −1144.10 | |
| Both | 0.050 (1.5%) | 0.068 (2.0%) | 1.7% | 33.1% | 20 | 2328.7 | −1144.34 | |
| Hospital | 0.057 (1.7%) | -- | 2.0% | 53.7% | 26 | 2330.2 | −1139.11 | |
| Surgeon | -- | 0.087 (2.6%) | 2.5% | 50.0% | 26 | 2329.6 | −1138.82 | |
| Both | 0.043 (1.3%) | 0.044 (1.3%) | 2.6% | 50.5% | 27 | 2331.8 | −1138.92 | |